8,818 Shares in Humana Inc. $HUM Bought by Ieq Capital LLC

Ieq Capital LLC purchased a new position in shares of Humana Inc. (NYSE:HUM) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 8,818 shares of the insurance provider’s stock, valued at approximately $3,502,000.

Other hedge funds also recently bought and sold shares of the company. Wilkerson Advisory Group LLC increased its stake in shares of Humana by 24.6% during the second quarter. Wilkerson Advisory Group LLC now owns 167 shares of the insurance provider’s stock worth $66,000 after buying an additional 33 shares during the period. Bogart Wealth LLC grew its holdings in Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after acquiring an additional 48 shares in the last quarter. Fiduciary Alliance LLC grew its holdings in Humana by 0.9% during the 1st quarter. Fiduciary Alliance LLC now owns 5,628 shares of the insurance provider’s stock worth $976,000 after acquiring an additional 49 shares in the last quarter. Sanctuary Advisors LLC increased its position in shares of Humana by 1.6% in the 4th quarter. Sanctuary Advisors LLC now owns 3,389 shares of the insurance provider’s stock valued at $868,000 after purchasing an additional 52 shares during the last quarter. Finally, Horizon Investments LLC raised its holdings in shares of Humana by 2.5% in the 4th quarter. Horizon Investments LLC now owns 2,236 shares of the insurance provider’s stock valued at $573,000 after purchasing an additional 55 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Cantor Fitzgerald increased their target price on Humana from $264.00 to $300.00 and gave the company a “neutral” rating in a report on Tuesday, July 7th. Mizuho upped their price objective on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. Wolfe Research reiterated an “outperform” rating and issued a $450.00 price objective on shares of Humana in a report on Monday. Truist Financial raised their target price on Humana from $320.00 to $415.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Finally, Robert W. Baird set a $390.00 price target on Humana in a report on Thursday, July 30th. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Hold” and an average price target of $403.91.

Humana Price Performance

Shares of NYSE HUM opened at $386.43 on Tuesday. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. Humana Inc. has a twelve month low of $163.11 and a twelve month high of $428.88. The stock has a 50 day moving average of $383.50 and a two-hundred day moving average of $283.61. The stock has a market cap of $46.40 billion, a P/E ratio of 36.56, a P/E/G ratio of 2.17 and a beta of 0.72.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. The business had revenue of $40.89 billion for the quarter, compared to analyst estimates of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The company’s revenue for the quarter was up 26.2% compared to the same quarter last year. During the same period last year, the firm posted $6.27 earnings per share. On average, research analysts forecast that Humana Inc. will post 9.08 earnings per share for the current year.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.